myBETAapp™
FREE
Get a link to download myBETAapp™
Enter your phone number below to receive a download link via text message. Visit this link from your mobile device to download this app.
Stats
#
6918
iPhone Rank
N/A
Weekly Change
Description
myBETAapp™ is a personal reminder and tracker for your BETASERON® (interferon beta-1b) injections, offered as part of the BETAPLUS™ program. This app makes it easy to remember when and where to inject BETASERON and to keep a diary that you can choose to share with your healthcare team. Read full description for IMPORTANT SAFETY INFORMATION and additional features.
FEATURES
•
... Read More See today’s plan at a glance: whether or not an injection is scheduled and, if so, where and when
• Customize which injection sites are included in your rotation schedule
• Choose whether or not to display an alert when it’s time for your next injection
• View your injection history and have the ability to email the list to yourself or your healthcare team (if email is configured on your device)
• Easy Access to the BETAPLUS patient support Web site and the toll-free
BETAPLUS patient support number (if you are an iPhone user with phone service).
myBETAapp may be used without entering any information that directly identifies you. Information that you record is stored only on your iPhone or iPod touch. Bayer HealthCare Pharmaceuticals does not collect personal information when you use the myBETAapp application. For more information about BETASERON please see our Web site, www.BETASERON.com, including Important Safety Information for BETASERON.
INDICATIONS AND USAGE
BETASERON® (interferon beta-1b) is indicated for the treatment of relapsing forms of multiple sclerosis to reduce the frequency of clinical exacerbations. Patients with multiple sclerosis in whom efficacy has been demonstrated include patients who have experienced a first clinical episode and have MRI features consistent with multiple sclerosis.
IMPORTANT SAFETY INFORMATION
The most commonly reported adverse reactions are lymphopenia, injection-site reaction, asthenia, flu-like symptom complex, headache, and pain. Gradual dose titration and use of analgesics during treatment initiation may help reduce flu-like symptoms. BETASERON should be used with caution in patients with depression. Injection-site necrosis has been reported in 4% of patients in controlled trials. Patients should be advised of the importance of rotating injection sites. Female patients should be warned about the potential risk to pregnancy. Cases of anaphylaxis have been reported rarely. See "Warnings," "Precautions," and "Adverse Reactions" sections of full Prescribing Information.
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.
To request medical or product information or to report an adverse event or product complaint, please call 1-888-842-2937 (1-888-84-BAYER).
For important risk and use information, please see the full prescribing information.
News 
Reviews
There were no reviews found.
Sun, 06 Jun 2010 19:03:46 UTC +00:00
